13 results on '"Conlon, Peter J"'
Search Results
2. Progression of renal artery stenosis in patients undergoing cardiac catheterization
- Author
-
Crowley, James J., Santos, Renato M., Peter, Robert H., Puma, Joseph A., Schwab, Steve J., Phillips, Harry R., Stack, Richard S., and Conlon, Peter J.
- Subjects
Arteries -- Stenosis ,Renal artery obstruction -- Development and progression ,Cardiac patients -- Physiological aspects ,Health - Published
- 1998
3. A population-based comparison of organ transplant recipients in whom cutaneous squamous cell develops versus those in whom basal cell carcinoma develops.
- Author
-
Menzies, Stephanie, O'Leary, Eamon, Callaghan, Grainne, Mansoor, Nazish, Deady, Sandra, Murad, Aizuri, Lenane, Patsy, O'Neill, Jim, Lally, Aoife, Houlihan, Diarmuid D., Murray, Susan, Sexton, Donal J., McCormick, P. Aiden, Egan, Jim J., O'Neill, James Paul, Conlon, Peter J., and Moloney, Fergal J.
- Published
- 2022
- Full Text
- View/download PDF
4. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever
- Author
-
Conlon, Peter J., Procop, Gary W., Fowler, Vance, Eloubeidi, Mohamed Ali, Smith, Stephen R., and Sexton, Daniel J.
- Subjects
Rocky Mountain spotted fever -- Prognosis ,Acute renal failure -- Risk factors ,Health ,Health care industry - Abstract
BACKGROUND: Acute renal failure has long been associated with severe Rocky Mountain spotted fever (RMSF). Despite many descriptions of the protean manifestations of this disease, relatively little is known concerning the risk factors for acute renal failure. Only a few studies have examined the outcome of patients infected with Rickettsia rickettsii who develop renal insufficiency, and these studies had methodological problems. OBJECTIVE: To study the incidence, risk factors, and outcomes of acute renal failure in a large group of hospitalized patients with definite or probable RMSF. METHODS: The clinical records of 114 patients with definite or probable RMSF were retrospectively reviewed to identify clinical and biochemical abnormalities at the time of admission that were associated with the development of acute renal failure and subsequent mortality. Renal failure was defined as a serum creatinine (Cr) above 2 mg/dL. Logistic regression was used to study the association between these variables and the outcomes during hospitalization: death and the development of acute renal failure. RESULTS: The mortality rate in this series was 14%; 19% of the patients developed acute renal failure. The development of acute renal failure increased the odds ratio (OR) of dying by a factor of 17 (P = 0.0001). Factors at the time of hospitalization that were associated at a univariate level with subsequent mortality included elevated serum Cr, increased age, increased level of AST, increased level of bilirubin, decreased serum sodium and platelet count, the presence of neurological involvement, and being male. Both the presence of neurological involvement and an elevated serum Cr at presentation were independently associated with increased mortality by multivariate analysis. Three patients developed acute renal failure that required hemodialysist and only 1 of these 3 patients survive ultimately discharged with a normal serum Cr. Factors at presentation that were associated with the development of acute renal failure included increased bilirubin, increasing age, thrombocytopenia, and the presence of neurological involvement. Both age and decreased platelet count at presentation were independently associated with the development of acute renal failure by multivariate analysis. CONCLUSION: Acute renal failure was a frequent complication of RMSF in this series of patients from a tertiary referral medical center. The presence of acute renal failure was strongly associated with death. Clinical and biochemical variables are useful in predicting which patients will develop acute renal failure. 1996 by Excerpta Medica, Inc. Am J Med. 1996;101:621-626.
- Published
- 1996
5. Arteriovenous fistula in dialysis patients: Factors implicated in early and late AVF maturation failure.
- Author
-
Bashar, Khalid, Conlon, Peter J., Kheirelseid, Elrasheid A.H., Aherne, Thomas, Walsh, Stewart R., and Leahy, Austin
- Subjects
- *
ARTERIOVENOUS fistula , *BLOOD-vessel abnormalities , *FISTULA , *KIDNEY disease diagnosis , *KIDNEY disease treatments , *HEMODIALYSIS , *TREATMENT of chronic kidney failure , *SURGICAL arteriovenous shunts , *CARDIOVASCULAR system physiology , *REOPERATION , *TIME , *TREATMENT effectiveness - Abstract
Increasing numbers of patients are being diagnosed with end-stage renal disease (ESRD), and the demand for on haemodialysis (HD) is rising. Arteriovenous fistulae (AVFs) remain the best conduit for adequate HD, with fewer complications associated with long-term use compared to bypass grafts and central venous catheters. However, it is known that many newly formed fistulae do not mature to provide useful HD access. The paper provides a narrative overview of factors influencing the process of AVF maturation failure. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery.
- Author
-
Swaminathan, Madhav, Phillips-Bute, Barbara G., Conlon, Peter J., Smith, Peter K., Newman, Mark F., and Stafford-Smith, Mark
- Subjects
KIDNEY injuries ,CARDIAC surgery ,CARDIOPULMONARY bypass ,CORONARY artery bypass - Abstract
: BackgroundAcute renal injury is a common serious complication of cardiac surgery. Moderate hemodilution is thought to reduce the risk of kidney injury but the current practice of extreme hemodilution (target hematocrit 22% to 24%) during cardiopulmonary bypass (CPB) has been linked to adverse outcomes after cardiac surgery. Therefore we tested the hypothesis that lowest hematocrit during CPB is independently associated with acute renal injury after cardiac surgery.: MethodsDemographic, perioperative, and laboratory data were gathered for 1,404 primary elective coronary bypass surgery patients. Preoperative and daily postoperative creatinine values were measured until hospital discharge per institutional protocol. Stepwise multivariable linear regression analysis was performed to determine whether lowest hematocrit during CPB was independently associated with peak fractional change in creatinine (defined as the difference between the preoperative and peak postoperative creatinine represented as a percentage of the preoperative value). A p value of less than 0.05 was considered significant.: ResultsMultivariable analyses including preoperative hematocrit and other perioperative variables revealed that lowest hematocrit during CPB demonstrated a significant interaction with body weight and was highly associated with peak fractional change in serum creatinine (parameter estimate [PE] = 4.5; p = 0.008) and also with highest postoperative creatinine value (PE = 0.06; p = 0.004). Although other renal risk factors were significant covariates in both models, TM50 (an index of hypotension during CPB) was notably absent.: ConclusionsThese results add to concerns that current CPB management guidelines accepting extreme hemodilution may contribute to postoperative acute renal and other organ injury after cardiac surgery. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
7. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.
- Author
-
Conlon, Peter J., Little, Mark A., Pieper, Karen, Mark, Daniel B., Conlon, P J, Little, M A, Pieper, K, and Mark, D B
- Subjects
- *
RENAL artery , *ARTERIAL stenosis , *ANGIOGRAPHY - Abstract
Background: Renal artery stenosis (RAS) is a relatively uncommon but potentially reversible cause of renal failure. In a previous report, we demonstrated that the presence of RAS is independently associated with mortality in a group of patients undergoing coronary angiography. Our current study expands on this cohort, investigating the effect of the severity of RAS on all-cause mortality.Methods: A total of 3987 patients underwent abdominal aortography immediately following coronary angiography. For the purpose of survival analysis, significant RAS was defined as > or =75% narrowing in the luminal diameter.Results: Significant RAS was present in 4.8% of patients studied and was bilateral in 0.8%. Factors associated with the presence of RAS included female gender, older age, hypertension, congestive heart failure, elevated serum creatinine, and congestive heart failure. The four-year unadjusted survivals for patients with and without significant RAS were 57 and 89%, respectively (P < 0.001). Using the Cox proportional hazards model, the factors independently associated with decreased survival were the presence of RAS, increased age, the severity of coronary artery disease, the presence of comorbid disease, reduced ejection fraction, symptoms of congestive cardiac failure, and the mode of treatment of coronary artery disease. In the multivariate model, the presence of RAS conferred a hazard ratio of 2.01 (95% CI, 1.51 to 2.67, P < 0.001). We demonstrated an incremental effect on mortality according to the severity of RAS at baseline. Four-year adjusted survival for patients with 50%, 75%, and > or =95% stenosis was 70%, 68%, and 48%, respectively. In addition, bilateral disease was associated with four-year survival of 47% as compared with 59% for patients with unilateral disease (P < 0.001). The impact of RAS on survival remained robust regardless of the manner of treatment of coronary artery disease [that is, medical, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass graft (CABG)].Conclusions: In this patient population, the presence of RAS is a strong independent predictor of mortality. Increasing severity of RAS has an incremental effect on survival probability. [ABSTRACT FROM AUTHOR]- Published
- 2001
- Full Text
- View/download PDF
8. Spectrum of disease in familial focal and segmental glomerulosclerosis.
- Author
-
Conlon, Peter J., Lynn, Kelvin, Winn, Michelle P., Quarles, L. Darryl, Bembe, Mary Lou, Pericak-Vance, Margaret, Speer, Marcy, and Howell, David N.
- Subjects
- *
KIDNEY glomerulus diseases , *KIDNEY diseases , *KIDNEY transplantation - Abstract
Spectrum of disease in familial focal and segmental glomerulosclerosis. Background. Focal segmental glomerulosclerosis (FSGS) is the underlying pathologic entity in 5% of adults and 20% of children with end-stage renal disease (ESRD). FSGS is generally considered to be sporadic in origin. Methods. Recently, we identified 60 families involving 190 individuals with familial FSGS, providing evidence for a subset of families in which a genetic form is segregating. Each family had at least one member with renal biopsy-confirmed FSGS and at least one other member with either renal biopsy-confirmed FSGS or ESRD. Results. Twenty-six families had individuals affected in more than one generation [multigeneration (MG)], and the remaining 34 families had only a single generation (SG) affected. There was equal representation of males and females among affected individuals. Ten percent of MG families were African American, and 52% of SG families were African American. The mean age of presentation was significantly higher in the MG families (32.5 ± 14.6 years) compared with the SG families (20.1 ± 12.1 years, P = 0.0001). SG cases had higher levels of proteinuria at presentation (7.0 ± 5.6 g/24 hr, compared with 3.8 ± 3.4 g/24 hr, for the MG families, P = 0.002). On renal biopsy, tubulointerstitial damage was more severe in patients in the SG families than in the MG families; however, the level of glomerular damage did not differ between these groups. Fifty percent of the patients had progressed to ESRD by the age of 30 years. Variables measured at presentation that were independently associated with poor renal survival were decreased age, increased serum creatinine, and increased urinary protein excretion. Forty-one patients underwent successful renal transplantation, with a 10-year graft survival rate of 62%. One patient developed clinical and biopsy evidence of recurrence of FSGS in the allograft. Conclusion. These data confirm the existence of a... [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
9. Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis.
- Author
-
Winn, Michelle P., Conlon, Peter J., Lynn, Kelvin L., Howell, David N., Gross, Deborah A., Rogala, Allison R., Smith, Anne H., Graham, Felicia L., Bembe, Marylou, Quarles, L. Daryl, Pericak-Vance, Margaret A., and Vance, Jeffery M.
- Subjects
- *
GENETIC disorders , *KIDNEY diseases - Abstract
Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. Background. Familial forms of focal segmental glomerulosclerosis (FFSGS) that exhibit autosomal dominant or recessive patterns of inheritance have been described. The genetic basis of these hereditary forms of FSGS is unknown. One recent study of a kindred from Oklahoma with an autosomal dominant form of FSGS linked this disease to a region of chromosome 19q. In addition, polymorphisms in a gene in this region on chromosome 19q13 have been linked to congenital nephrotic syndrome of the Finnish type. We have ascertained and characterized a large family with autosomal dominant FFSGS (Duke 6530). Methods. Families were compared for clinical and genetic heterogeneity. To test for linkage of our family to this portion of chromosome 19, genomic DNA was isolated from 102 family members, and polymerase chain reaction was performed using eight microsatellite markers that spanned the area of interest on chromosome 19. Data were evaluated using two-point linkage analysis, multipoint analysis, and an admixture test. Results. Linkage was excluded at a distance of ±5 to 10 cm for all markers tested with two-point log10 of the odds of linkage (LOD) scores and from an approximate 60 cm interval in this area of chromosome 19q via multipoint analysis. Conclusions. FSGS has been called the “final common pathway” of glomerular injury, as it is a frequent pathological manifestation with diverse etiologies. This diversity likely correlates with the genetic heterogeneity that we have established. Thus, our data demonstrate that there are at least two genes responsible for this disease, and there is genetic as well as clinical heterogeneity in autosomal dominant FSGS. [ABSTRACT FROM AUTHOR]
- Published
- 1999
10. Understanding What Influences the Health-Related Quality of Life of Hemodialysis Patients: A Collaborative Study in England and Ireland.
- Author
-
Lowney, Aoife C., Myles, Helena T., Bristowe, Katherine, Lowney, Eanna L., Shepherd, Katie, Murphy, Marie, O'Brien, Tony, Casserly, Liam, McQuillan, Regina, Plant, William D., Conlon, Peter J., Vinen, Catherine, Eustace, Joseph A., Murtagh, Fliss E.M., and O'Brien, Tony
- Subjects
- *
QUALITY of life , *HEMODIALYSIS patients , *NEPHROLOGISTS , *MEDICAL care , *CHRONIC disease treatment , *TREATMENT of chronic kidney failure , *HEMODIALYSIS , *PAIN & psychology , *PALLIATIVE treatment , *CHRONIC kidney failure , *COMPARATIVE studies , *ECONOMIC aspects of diseases , *RESEARCH methodology , *MEDICAL cooperation , *PAIN , *PSYCHOLOGICAL tests , *REGRESSION analysis , *RESEARCH , *EVALUATION research , *CROSS-sectional method , *SEVERITY of illness index , *PSYCHOLOGY - Abstract
Context: The international cohort of hemodialysis patients is aging and increasing in number. Nephrologists have a therapeutic relationship with their patients that may span decades. Often overlooked components of chronic disease management include symptom control and assessment of health-related quality of life (HRQoL).Objectives: This study describes the symptom profile of a large cohort of patients with end-stage renal disease on hemodialysis in England and Ireland and evaluates how symptom burden and other factors influence quality-of-life scores.Methods: A prospective cross-sectional observational study of hemodialysis patients was conducted in Ireland and England during 2011 and 2012. Two validated clinical tools were used to determine HRQoL and symptom burden. Demographic and clinical data were examined, and regression analysis was used to determine associations with HRQoL scores.Results: A total of 893 patients on hemodialysis (mean [SD] age 64 [16] years) had a high symptom burden and poor HRQoL compared with population norms. Specifically, 64% of patients reported pain (95% confidence interval 61%-67%) and 79% reported weakness (95% confidence interval 75%-81%). A total of 43 percent of patients reported between six and 10 symptoms in the week preceding the survey. HRQoL was significantly and independently associated with poor mobility and pain and remained significant after adjusting for variations in clinical characteristics. Being listed on a transplant wait-list register was positively associated with HRQoL.Conclusion: These findings illustrate the high symptom burden and poor HRQoL of the hemodialysis population. Emphasis during clinical reviews on pain assessment and on assessing mobility plus interventions, such as pain management and physiotherapy/occupational therapy, are practical ways for renal teams to help improve patients' quality of life. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
11. Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.
- Author
-
Malone, Andrew F, Phelan, Paul J, Hall, Gentzon, Cetincelik, Umran, Homstad, Alison, Alonso, Andrea S, Jiang, Ruiji, Lindsey, Thomas B, Wu, Guanghong, Sparks, Matthew A, Smith, Stephen R, Webb, Nicholas J A, Kalra, Philip A, Adeyemo, Adebowale A, Shaw, Andrey S, Conlon, Peter J, Jennette, J Charles, Howell, David N, Winn, Michelle P, and Gbadegesin, Rasheed A
- Subjects
- *
KIDNEY glomerulus diseases , *HEMATURIA , *PROTEINURIA , *GENETIC disorders , *GENES - Abstract
Focal segmental glomerulosclerosis (FSGS) is a histological lesion with many causes, including inherited genetic defects, with significant proteinuria being the predominant clinical finding at presentation. Mutations in COL4A3 and COL4A4 are known to cause Alport syndrome (AS), thin basement membrane nephropathy, and to result in pathognomonic glomerular basement membrane (GBM) findings. Secondary FSGS is known to develop in classic AS at later stages of the disease. Here, we present seven families with rare or novel variants in COL4A3 or COL4A4 (six with single and one with two heterozygous variants) from a cohort of 70 families with a diagnosis of hereditary FSGS. The predominant clinical finding at diagnosis was proteinuria associated with hematuria. In all seven families, there were individuals with nephrotic-range proteinuria with histologic features of FSGS by light microscopy. In one family, electron microscopy showed thin GBM, but four other families had variable findings inconsistent with classical Alport nephritis. There was no recurrence of disease after kidney transplantation. Families with COL4A3 and COL4A4 variants that segregated with disease represent 10% of our cohort. Thus, COL4A3 and COL4A4 variants should be considered in the interpretation of next-generation sequencing data from such patients. Furthermore, this study illustrates the power of molecular genetic diagnostics in the clarification of renal phenotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial.
- Author
-
Holdaas, Hallvard, Jardine, Alan G., Wheeler, David C., Brekke, Inge B., Conlon, Peter J., Fellstrøm, Bengt, Hammad, Abdel, Holme, Ingar, Isoniemi, Helena, Moore, Richard, Rowe, Peter A., Sweny, Paul, Talbot, David A., Wadstrøm, Jonas, and Østraat, Øyvind
- Subjects
- *
STATINS (Cardiovascular agents) , *HOMOGRAFTS , *KIDNEY transplantation - Abstract
Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial. Background. Statin therapy has been reported to reduce the acute rejection rate following renal transplantation in a pilot study. The present study is the first randomized, double-blind and adequately powered study to examine the effect of statins on acute rejection of renal allografts. Methods. A total of 364 patients were randomly assigned to receive either fluvastatin 40 mg or placebo in combination with conventional cyclosporine-based immunosuppressive therapy. The primary end point was treated first acute rejection. Secondary end points included biopsy-proven rejection, histological severity of rejection, occurrence of steroid-resistant rejection, and serum creatinine at three months following transplantation. Results. Fluvastatin was well tolerated; no patients developed myositis or rhabdomyolysis. There was no difference in the acute rejection rate [86 (47.3%) fluvastatin vs. 87 (47.8%) placebo] and no significant difference in the severity of rejection, steroid resistant rejection or mean serum creatinine at three months (160 μmol/L vs. 160 μmol/L). Total cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and triglyceride levels increased following renal transplantation. With the exception of the increase in HDL-C, which was augmented, the increases in lipid parameters were significantly reduced by fluvastatin (total cholesterol +17.5% vs. 35.7%; LDL-C +6.3% vs. 46.7%; HDL-C +43.3% vs. 38.1%; triglyceride +52.2% vs 77.6%). Conclusions. Contrary to the reported effects of statins, fluvastatin had no effect on the incidence or severity of acute rejection following renal transplantation. There were no increases in adverse events. A significant and potentially beneficial alteration in the lipid profile was observed in the early post transplant period. We conclude that fluvastatin may be used safely to correct dyslipidemia... [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
13. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients.
- Author
-
Marr, Kieren A., Kong, LiKuo, Fowler, Vance G., Gopal, Ajay, Sexton, Daniel J., Conlon, Peter J., Corey, G. Ralph, Marr, K A, Kong, L, Fowler, V G, Gopal, A, Sexton, D J, Conlon, P J, and Corey, G R
- Subjects
- *
STAPHYLOCOCCUS aureus , *HEMODIALYSIS - Abstract
Background: Staphylococcus aureus bacteremia is frequently associated with metastatic complications and infective endocarditis (IE). The Duke criteria for the diagnosis of IE utilize echocardiographic techniques and are more sensitive than previous criteria. The documentation of IE in patients undergoing hemodialysis (HD) has become increasingly important in order to avoid the overuse of empiric vancomycin and the emergence of antibiotic resistance.Methods: Patients who developed S. aureus bacteremia while undergoing HD at a tertiary medical center or one of four affiliated outpatient HD units were identified. Clinical outcome (death, metastatic complications, IE, and microbiologic recurrence) was assessed during hospitalization and at three months after discharge. Transthoracic and transesophageal echocardiograms were performed and the Duke criteria were used to diagnose IE. Pulse field gel electrophoresis was performed to confirm genetic similarity of recurrent isolates.Results: Four hundred and forty-five patients underwent hemodialysis for 5431.8 patient-months. Sixty-two developed 65 episodes of S. aureus bacteremia (1.2 episodes/100 patient-months). Complications occurred in 27 (44%) patients. Bacteremia recurred in patients who dialyzed through polytetrafluorethylene grafts (44.4% vs. 7.1%, P = 0.0.01), and there was a trend to increased recurrence in patients who received only vancomycin (19.5% vs. 7.1%, P = 0.4). IE was diagnosed in 8 patients (12%), six of whom had normal transthoracic echocardiograms.Conclusions: Sensitive echocardiographic techniques and the Duke criteria for the diagnosis of IE should be used to determine the proper duration of antibiotic therapy in hemodialysis patients with S. aureus bacteremia. This diagnostic approach, coupled with early removal of hardware, may assist in improving outcomes. [ABSTRACT FROM AUTHOR]- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.